Agilent Technologies Inc (NYSE:A) fell 11% on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $66.24 and last traded at $67.64. 14,474,331 shares traded hands during trading, an increase of 613% from the average session volume of 2,031,359 shares. The stock had previously closed at $76.01.

The medical research company reported $0.71 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.90% and a net margin of 22.86%. Agilent Technologies’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.65 earnings per share.

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd were paid a $0.164 dividend. The ex-dividend date of this dividend was Monday, April 1st. This represents a $0.66 annualized dividend and a yield of 0.97%. Agilent Technologies’s payout ratio is 23.66%.

A number of equities research analysts have recently commented on the company. Deutsche Bank reissued a “buy” rating and issued a $90.00 target price on shares of Agilent Technologies in a research note on Thursday, February 21st. Robert W. Baird reaffirmed a “buy” rating and set a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research report on Wednesday, February 20th. Needham & Company LLC reaffirmed a “buy” rating and set a $88.00 price objective (up from $77.00) on shares of Agilent Technologies in a research report on Monday, February 25th. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, January 23rd. Finally, Barclays increased their price objective on Agilent Technologies from $80.00 to $83.00 and gave the company an “overweight” rating in a research report on Thursday, February 21st. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $86.58.

In other news, VP Mark Doak sold 16,421 shares of the firm’s stock in a transaction dated Friday, February 22nd. The stock was sold at an average price of $77.95, for a total value of $1,280,016.95. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Michael Tang sold 6,728 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $80.50, for a total value of $541,604.00. The disclosure for this sale can be found here. In the last three months, insiders sold 57,329 shares of company stock worth $4,535,225.

Large investors have recently added to or reduced their stakes in the stock. Destination Wealth Management grew its holdings in Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after buying an additional 200 shares in the last quarter. Captrust Financial Advisors grew its holdings in Agilent Technologies by 2,121.1% during the 4th quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock valued at $29,000 after buying an additional 403 shares in the last quarter. Lake Point Wealth Management purchased a new position in Agilent Technologies during the 4th quarter valued at approximately $30,000. Cresset Asset Management LLC purchased a new position in Agilent Technologies during the 1st quarter valued at approximately $37,000. Finally, JOYN Advisors Inc. boosted its holdings in shares of Agilent Technologies by 186.6% in the 4th quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after purchasing an additional 306 shares during the period.

The firm has a market capitalization of $23.45 billion, a P/E ratio of 24.24, a P/E/G ratio of 2.05 and a beta of 1.33. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

COPYRIGHT VIOLATION WARNING: “Agilent Technologies (A) Shares Down 11% on Disappointing Earnings” was originally published by Marea Informative and is the property of of Marea Informative. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.mareainformativa.com/news/2019/05/15/agilent-technologies-a-shares-down-11-on-disappointing-earnings.html.

Agilent Technologies Company Profile (NYSE:A)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Why do commodities matter?

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.